Enzymatic Deacylation of Teicoplanin Followed by Reductive Alkylation: Synthesis and Antibacterial Activity of New Glycopeptides
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-10-25
著者
-
Cooper Robin
Lilly Research Laboratories Eli Lilly And Company
-
Snyder Nancy
Lilly Research Laboratories Eli Lilly And Company
-
NICAS THALIA
Lilly Research Laboratories, Eli Lilly and Company
-
MULLEN DEBORAH
Lilly Research Laboratories, Eli Lilly and Company
-
Nicas Thalia
Lilly Research Laboratories Eli Lilly And Company
-
Mullen Deborah
Lilly Research Laboratories Eli Lilly And Company
-
BRIGGS Barbara
Lilly Research Laboratories, Eli Lilly and Company
-
ZMIJEWSKI Milton
Lilly Research Laboratories, Eli Lilly and Company
-
KAISER Raymond
Lilly Research Laboratories, Eli Lilly and Company
-
Kaiser Raymond
Lilly Research Laboratories Eli Lilly And Company
-
Briggs Barbara
Lilly Research Laboratories Eli Lilly And Company
-
Zmijewski Milton
Lilly Research Laboratories Eli Lilly And Company
関連論文
- Glycopeptide Carboxamides Active against Vancomycin-resistant Enterococci
- Novel Glycopeptide Antibiotics: N-Alkylated Derivatives Active Against Vancomycin-Resistant Enterococci
- Tripeptide LY301621 and Its Diastereomers as Methicillin Potentiators against Methicillin Resistant Staphylococcus aureus
- Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity
- Enzymatic Deacylation of Teicoplanin Followed by Reductive Alkylation: Synthesis and Antibacterial Activity of New Glycopeptides